33515532 35339914 32914709 31755573 33397405 32130916 30370857 31597327 - Search Results

Year	Number of Results
2019	3
2020	3
2021	2
2022	1

1

Targeting signal pathways triggered by cyclic peptides in cancer: Current trends and future challenges.

Yang Y, Mao H, Chen L, Li L. Yang Y, et al. Arch Biochem Biophys. 2021 Apr 15;701:108776. doi: 10.1016/j.abb.2021.108776. Epub 2021 Jan 27. Arch Biochem Biophys. 2021. PMID: 33515532 Review.

2

Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation.

Faskhoudi MA, Molaei P, Sadrkhanloo M, Orouei S, Hashemi M, Bokaie S, Rashidi M, Entezari M, Zarrabi A, Hushmandi K, Mirzaei S, Gholami MH. Faskhoudi MA, et al. Pathol Res Pract. 2022 May;233:153851. doi: 10.1016/j.prp.2022.153851. Epub 2022 Mar 21. Pathol Res Pract. 2022. PMID: 35339914 Review.

3

Resistance to paclitaxel induces glycophenotype changes and mesenchymal-to-epithelial transition activation in the human prostate cancer cell line PC-3.

da Fonseca LM, Calvalhan DM, Previato JO, Mendonça Previato L, Freire-de-Lima L. da Fonseca LM, et al. Tumour Biol. 2020 Sep;42(9):1010428320957506. doi: 10.1177/1010428320957506. Tumour Biol. 2020. PMID: 32914709 Free article.

4

Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.

Guo B, Wu S, Zhu X, Zhang L, Deng J, Li F, Wang Y, Zhang S, Wu R, Lu J, Zhou Y. Guo B, et al. EMBO J. 2020 Jan 2;39(1):e102190. doi: 10.15252/embj.2019102190. Epub 2019 Nov 22. EMBO J. 2020. PMID: 31755573 Free PMC article.

5

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.

Madden SK, de Araujo AD, Gerhardt M, Fairlie DP, Mason JM. Madden SK, et al. Mol Cancer. 2021 Jan 4;20(1):3. doi: 10.1186/s12943-020-01291-6. Mol Cancer. 2021. PMID: 33397405 Free PMC article. Review.

6

PP2A_C Phospho-Tyr³⁰⁷ Antibodies Are Not Specific for this Modification but Are Sensitive to Other PP2A_C Modifications Including Leu³⁰⁹ Methylation.

Frohner IE, Mudrak I, Schüchner S, Anrather D, Hartl M, Sontag JM, Sontag E, Wadzinski BE, Preglej T, Ellmeier W, Ogris E. Frohner IE, et al. Cell Rep. 2020 Mar 3;30(9):3171-3182.e6. doi: 10.1016/j.celrep.2020.02.035. Cell Rep. 2020. PMID: 32130916 Free article.

7

Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature.

Kopalli SR, Kang TB, Lee KH, Koppula S. Kopalli SR, et al. Recent Pat Anticancer Drug Discov. 2019;14(2):100-112. doi: 10.2174/1574892813666181029142812. Recent Pat Anticancer Drug Discov. 2019. PMID: 30370857 Review.

8

Dietary Compounds for Targeting Prostate Cancer.

Noh S, Choi E, Hwang CH, Jung JH, Kim SH, Kim B. Noh S, et al. Nutrients. 2019 Oct 8;11(10):2401. doi: 10.3390/nu11102401. Nutrients. 2019. PMID: 31597327 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results